iShares Genomics Immunology and Healthcare ETF (IDNA) Short Interest Ratio & Short Volume

Short interest is the volume of iShares Genomics Immunology and Healthcare ETF shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 4,600 shares of IDNA short. 0.09% of iShares Genomics Immunology and Healthcare ETF's shares are currently sold short. Learn More on iShares Genomics Immunology and Healthcare ETF's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.09% of iShares Genomics Immunology and Healthcare ETF's floating shares are currently sold short.

iShares Genomics Immunology and Healthcare ETF saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 4,600 shares, a decline of 31.3% from the previous total of 6,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.09% of iShares Genomics Immunology and Healthcare ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares Genomics Immunology and Healthcare ETF: Inspire Fidelis Multi Factor ETF (0.17%), First Trust Indxx Innovative Transaction & Process ETF (0.08%), iShares MSCI Agriculture Producers ETF (1.86%), Amplify Alternative Harvest ETF (1.24%), Sovereigns Capital Flourish Fund (0.15%), iShares ESG Advanced MSCI EM ETF (0.60%), KraneShares China Internet and Covered Call Strategy ETF (1.16%), Schwab Crypto Thematic ETF (0.21%), VanEck Low Carbon Energy ETF (0.01%), Innovator Deepwater Frontier Tech ETF (1.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

Short selling IDNA is an investing strategy that aims to generate trading profit from iShares Genomics Immunology and Healthcare ETF as its price is falling. IDNA shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Genomics Immunology and Healthcare ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IDNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDNA, twice per month. The most recent reporting period available is June, 15 2025.